Med 20 mg dosen (n=19) faldt middel plasma kolesterolniveauet med 39, 3% (p < 0, 05), og middel plasma triglyceridniveauet faldt med 41, 8% (ns); der var et fald i VLDL- kolesterol på 44, 8% (ns), et fald i LDL- kolesterol på 36, 5% (p < 0, 01) og en stigning i HDL- kolesterol på 18, 1% (ns).
With the 20-mg dose (n=19) the mean plasma cholesterol level decreased by 39.3% (p < 0.05), and the mean plasma triglycerides level decreased by 41.8% (ns); there was a decrease in VLDL cholesterol of 44.8% (ns), a decrease in LDL cholesterol of 36.5% (p < 0.01), and an increase in HDL cholesterol of 18.1% (ns).